de Porto, A. P., Liu, Z., de Beer, R., Florquin, S., de Boer, O. J., Hendriks, R. W., . . . de Vos, A. F. (2019). Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. Molecular medicine (Cambridge, Mass.), 25(1), 3-10. https://doi.org/10.1186/s10020-018-0069-7
Citace podle Chicago (17th ed.)de Porto, Alexander P., Zhe Liu, Regina de Beer, Sandrine Florquin, Onno J. de Boer, Rudi W. Hendriks, Tom van der Poll, a Alex F. de Vos. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.) 25, no. 1 (2019): 3-10. https://doi.org/10.1186/s10020-018-0069-7.
Citace podle MLA (9th ed.)de Porto, Alexander P., et al. "Btk Inhibitor Ibrutinib Reduces Inflammatory Myeloid Cell Responses in the Lung During Murine Pneumococcal Pneumonia." Molecular Medicine (Cambridge, Mass.), vol. 25, no. 1, 2019, pp. 3-10, https://doi.org/10.1186/s10020-018-0069-7.